Cited by 42

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Enhanced Tumor Targeting and Penetration of Proteolysis-Targeting Chimeras through iRGD Peptide Conjugation: A Strategy for Precise Protein Degradation in Breast Cancer

He, Shipeng, Fang, Yuxin, Wu, Minghao, Zhang, Peifeng, Gao, Fei, Hu, Honggang, Sheng, Chunquan, Dong, Guoqiang·2023·Journal of Medicinal Chemistry

Abstract

Proteolysis-targeting chimeras (PROTACs) have recently emerged as a promising technology for drug development. However, poor water solubility, limited tissue selectivity, and inadequate tumor penetration pose significant challenges for PROTAC-based therapies in cancer treatment. Herein, we developed an iRGD-PROTAC conjugation strategy utilizing tumor-penetrating cyclic peptide iRGD (CRGDK/RGPD/EC) to deliver PROTACs deep into breast cancer tissues. As a conceptual validation study, iRGD peptides were conjugated with a bromodomain-containing protein 4 (BRD4) PROTAC through a GSH-responsive linker. The resulting iRGD-PROTAC conjugate iPR showed enhanced water solubility, tumor-targeting capability, and penetration within tumor tissues, resulting in increased antibreast cancer efficacy in animal models and patient-derived organoids. This study demonstrates the advantages of combining iRGD and PROTACs in improving drug delivery and highlights the importance of tissue selectivity and penetration ability in PROTAC-based therapeutics.

Overview

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.3c01539

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 8 references

Research works printed but not linked: 30

  1. 10.1038/s41573-021-00371-6 · DOI · Paper page
  2. 10.1038/s41568-021-00365-x · DOI
  3. 10.1038/s41589-019-0362-y · DOI · Paper page
  4. 10.1002/med.21877 · DOI
  5. 10.1016/j.cell.2019.11.031 · DOI · Paper page
  6. 10.1016/j.cej.2023.143883 · DOI
  7. 10.1002/anie.202107347 · DOI
  8. 10.1021/jacs.1c00451 · DOI
  9. 10.1038/s41467-021-23194-w · DOI
  10. 10.1021/acschembio.0c00285 · DOI · Paper page
  11. 10.1038/nm720 · DOI
  12. 10.1016/j.addr.2016.03.008 · DOI
  13. 10.1038/nrc3627 · DOI
  14. 10.1016/S0092-8674(00)81402-6 · DOI
  15. 10.1073/pnas.2112457118 · DOI
  16. 10.1073/pnas.0908201106 · DOI · Paper page
  17. 10.1182/blood-2008-04-150342 · DOI
  18. 10.1016/j.addr.2015.12.001 · DOI
  19. 10.1016/j.ccr.2009.10.013 · DOI
  20. 10.1016/j.jconrel.2016.06.032 · DOI
  21. 10.1186/s13045-020-00885-3 · DOI
  22. 10.1016/j.chembiol.2015.05.009 · DOI · Paper page
  23. 10.1073/pnas.1521738113 · DOI · Paper page
  24. 10.1021/acs.jmedchem.8b01196 · DOI
  25. 10.1016/j.biomaterials.2014.06.042 · DOI
  26. 10.1016/j.drudis.2022.103387 · DOI
  27. Gasparini G., 1998, Clin. Cancer Res., 4, 2625
  28. 10.1016/j.semcancer.2019.08.012 · DOI
  29. 10.1172/JCI92284 · DOI
  30. 10.1038/s41467-017-01565-6 · DOI

Cited by

Sorted by citations

See all 42

Metadata

Authors
He, S., Fang, Y., Wu, M., Zhang, P., Gao, F., Hu, H., Sheng, C., & Dong, G.
Venue
Journal of Medicinal Chemistry
Published
2023-12-06
Volume
66
Issue
24
Pages
16828-16842
ISSN
  • 0022-2623
  • 1520-4804
Cited by
42
References
8
Language
en
Funders
  • National Key Research and Development Program of China (2022YFC3401500)
  • National Natural Science Foundation of China (82030105, 82273779, 82003567)
  • Shanghai Rising-Star Program (23QA1403500)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhanced Tumor Targeting and Penetration of Proteolysis-Targeting Chimeras through iRGD Peptide Conjugation: A Strategy for Precise Protein Degradation in Breast Cancer. https://app.cochat.ai/papers/10.1021/acs.jmedchem.3c01539
The paper
He, S., Fang, Y., Wu, M., Zhang, P., Gao, F., Hu, H., Sheng, C., & Dong, G. (2023). Enhanced Tumor Targeting and Penetration of Proteolysis-Targeting Chimeras through iRGD Peptide Conjugation: A Strategy for Precise Protein Degradation in Breast Cancer. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01539